Variant report

Variant	esv1826457
Chromosome Location	chr4:119315822-119387097
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:665)
CpG islands
(count:61)
Chromatin interactive
region (count:3)
LncRNA
region (count:4)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:665 , 50 per page) page: 1 2 3 4 5 6 7 ... 14

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF2	chr4:119319359-119319713	GM12878	blood:	n/a	n/a
2	BATF	chr4:119340637-119341181	GM12878	blood:	n/a	chr4:119340900-119340911
3	BATF	chr4:119349910-119350272	GM12878	blood:	n/a	n/a
4	BATF	chr4:119346684-119346850	GM12878	blood:	n/a	n/a
5	BATF	chr4:119340543-119341192	GM12878	blood:	n/a	chr4:119340900-119340911
6	BATF	chr4:119319432-119319704	GM12878	blood:	n/a	n/a
7	BCL11A	chr4:119357419-119357683	GM12878	blood:	n/a	n/a
8	BCL11A	chr4:119346839-119347055	GM12878	blood:	n/a	n/a
9	BCL11A	chr4:119340615-119341149	GM12878	blood:	n/a	chr4:119340900-119340909
10	BCL11A	chr4:119345259-119345545	GM12878	blood:	n/a	n/a
11	BCL11A	chr4:119349658-119349869	GM12878	blood:	n/a	n/a
12	BCL11A	chr4:119348069-119348301	GM12878	blood:	n/a	n/a
13	BCL11A	chr4:119340729-119341128	GM12878	blood:	n/a	chr4:119340900-119340909
14	BCL11A	chr4:119347436-119347664	GM12878	blood:	n/a	n/a
15	BCL11A	chr4:119366080-119366250	GM12878	blood:	n/a	n/a
16	BCL3	chr4:119382599-119382899	GM12878	blood:	n/a	n/a
17	BHLHE40	chr4:119319505-119319677	GM12878	blood:	n/a	n/a
18	CEBPB	chr4:119331341-119331666	IMR90	lung:	n/a	n/a
19	CEBPB	chr4:119376054-119376279	IMR90	lung:	n/a	n/a
20	CEBPB	chr4:119338475-119338816	IMR90	lung:	n/a	n/a
21	CEBPB	chr4:119382583-119382910	IMR90	lung:	n/a	chr4:119382722-119382733
22	CEBPB	chr4:119340970-119341155	Hela-S3	cervix:	n/a	chr4:119340996-119341007 chr4:119341094-119341111 chr4:119340996-119341009
23	CEBPB	chr4:119351771-119351934	K562	blood:	n/a	n/a
24	CEBPB	chr4:119340964-119341126	HepG2	liver:	n/a	chr4:119340996-119341007 chr4:119341094-119341111 chr4:119340996-119341009
25	CEBPB	chr4:119337044-119337239	IMR90	lung:	n/a	n/a
26	CEBPB	chr4:119340977-119341100	IMR90	lung:	n/a	chr4:119340996-119341007 chr4:119340996-119341009
27	CHD1	chr4:119318579-119318678	GM12878	blood:	n/a	n/a
28	CHD2	chr4:119345423-119345555	H1-hESC	embryonic stem cell:	n/a	n/a
29	CTCF	chr4:119358119-119358155	GM20000	blood:	n/a	n/a
30	CTCF	chr4:119345359-119345473	GM10248	blood:	n/a	n/a
31	CTCF	chr4:119344940-119345090	SAEC	small airway:	n/a	n/a
32	CTCF	chr4:119345380-119345530	HPF	lung:	n/a	n/a
33	CTCF	chr4:119345300-119345450	HA-sp	spinal cord:	n/a	n/a
34	CTCF	chr4:119345300-119345450	GM12874	blood:	n/a	n/a
35	CTCF	chr4:119345306-119345491	Hela-S3	cervix:	n/a	n/a
36	CTCF	chr4:119321560-119321710	AG04450	lung:	n/a	n/a
37	CTCF	chr4:119345324-119345462	SK-N-SH_RA	brain:	n/a	n/a
38	CTCF	chr4:119345320-119345470	HCM	heart:	n/a	n/a
39	CTCF	chr4:119353291-119353306	MCF-7	breast:	n/a	n/a
40	CTCF	chr4:119345320-119345470	HMEC	breast:	n/a	n/a
41	CTCF	chr4:119345314-119345496	HUVEC	blood vessel:	n/a	n/a
42	CTCF	chr4:119345320-119345470	RPTEC	kidney:	n/a	n/a
43	CTCF	chr4:119345380-119345530	AG09319	gingival:	n/a	n/a
44	CTCF	chr4:119345276-119345547	Medullo	brain:	n/a	n/a
45	CTCF	chr4:119345380-119345530	HEEpiC	esophagus:	n/a	n/a
46	CTCF	chr4:119345380-119345530	K562	blood:	n/a	n/a
47	CTCF	chr4:119353285-119353314	K562	blood:	n/a	n/a
48	CTCF	chr4:119345300-119345450	Hela-S3	cervix:	n/a	n/a
49	CTCF	chr4:119345300-119345450	HUVEC	blood vessel:	n/a	n/a
50	CTCF	chr4:119345380-119345530	HUVEC	blood vessel:	n/a	n/a

(count:61 , 50 per page) page: 1 2

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr4:119318892-119318942	SKMC	muscle:	n/a
2	chr4:119318892-119318942	U87	brain:	n/a
3	chr4:119318892-119318942	ProgFib	skin:	n/a
4	chr4:119318892-119318942	HNPCEpiC	eye:	n/a
5	chr4:119318892-119318942	H1-hESC	embryonic stem cell:	embryo
6	chr4:119318892-119318942	ECC-1	luminal epithelium:	n/a
7	chr4:119318892-119318942	HEK293	kidney:	embryo
8	chr4:119318892-119318942	BJ	skin:	n/a
9	chr4:119318892-119318942	HepG2	liver:	n/a
10	chr4:119318892-119318942	HEEpiC	esophagus:	n/a
11	chr4:119318892-119318942	HCPEpiC	choroid plexus:	n/a
12	chr4:119318892-119318942	GM19239	blood:	n/a
13	chr4:119318892-119318942	HUVEC	blood vessel:	n/a
14	chr4:119318892-119318942	AG04449	skin:	fetal
15	chr4:119318892-119318942	GM06990	blood:	n/a
16	chr4:119318892-119318942	SK-N-SH	brain:	n/a
17	chr4:119318892-119318942	NHBE	bronchial:	n/a
18	chr4:119318892-119318942	AoSMC	blood vessel:	n/a
19	chr4:119318892-119318942	IMR90	lung:	fetal
20	chr4:119318892-119318942	HMEC	breast:	n/a
21	chr4:119318892-119318942	HRE	kidney:	n/a
22	chr4:119318892-119318942	BE2_C	brain:	n/a
23	chr4:119318892-119318942	HAEpiC	amniotic membrane:	n/a
24	chr4:119318892-119318942	HL-60	blood:	n/a
25	chr4:119318892-119318942	HRPEpiC	eye:	n/a
26	chr4:119318892-119318942	SK-N-SH_RA	brain:	n/a
27	chr4:119318892-119318942	GM12878	blood:	n/a
28	chr4:119318892-119318942	K562	blood:	n/a
29	chr4:119318892-119318942	GM12892	blood:	n/a
30	chr4:119318892-119318942	HRCEpiC	kidney:	n/a
31	chr4:119318892-119318942	AG09309	skin:	n/a
32	chr4:119318892-119318942	CMK	blood:	n/a
33	chr4:119318892-119318942	HPAEpiC	pulmonary alveolar:	n/a
34	chr4:119318892-119318942	HCT-116	colon:	n/a
35	chr4:119318892-119318942	NHDF-neo	bronchial:	n/a
36	chr4:119318892-119318942	AG10803	skin:	n/a
37	chr4:119318892-119318942	LNCaP	prostate:	n/a
38	chr4:119318892-119318942	NH-A	brain:	n/a
39	chr4:119318892-119318942	HIPEpiC	eye:	n/a
40	chr4:119318892-119318942	HCF	heart:	n/a
41	chr4:119318892-119318942	ovcar-3	ovarian:	n/a
42	chr4:119318892-119318942	MCF10A-Er-Src	breast:	n/a
43	chr4:119318892-119318942	AG04450	lung:	fetal
44	chr4:119318892-119318942	PFSK-1	brain:	n/a
45	chr4:119318892-119318942	Caco-2	colon:	n/a
46	chr4:119318892-119318942	Hela-S3	cervix:	n/a
47	chr4:119318892-119318942	SK-N-MC	brain:	n/a
48	chr4:119318892-119318942	PrEC	prostate:	n/a
49	chr4:119318892-119318942	Jurkat	blood:	n/a
50	chr4:119318892-119318942	A549	lung:	n/a

(count:3 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr4:119198536..119201399-chr4:119334515..119337557,3	MCF-7	breast:
2	chr4:119311600..119313151-chr4:119317635..119319995,2	MCF-7	breast:
3	chr4:119199281..119200962-chr4:119368800..119371509,2	MCF-7	breast:

(count:4 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-NDST3-3	chr4:119349734-119350000	XLOC_003661
2	lnc-PRSS12-1	chr4:119321669-119321989	NONHSAT097980
3	lnc-NDST3-3	chr4:119350138-119350584	XLOC_003661
4	lnc-NDST3-3	chr4:119348948-119349038	XLOC_003661

No data

Variant related genes	Relation type
CEP170P1	TF binding region
NDUFS5P5	TF binding region
CEP170P1	CpG island
NDUFS5P5	CpG island
ENSG00000269893	chromatin interactions

Extended variants
information (count: 1579 )
Associated
traits (count: 76 )

Variant overlapped rSNPs/rCNVs (count:1579 , 50 per page) page: 1 2 3 4 5 6 7 ... 32

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs566315494	chr4:119315829-119315830	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
2	rs563139199	chr4:119315850-119315851	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs139476331	chr4:119315861-119315862	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs75777668	chr4:119315949-119315950	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs565518686	chr4:119316055-119316056	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
6	rs62328887	chr4:119316064-119316065	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
7	rs373698995	chr4:119316095-119316096	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
8	rs113030435	chr4:119316155-119316156	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
9	rs376400161	chr4:119316158-119316159	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
10	rs142826415	chr4:119316187-119316188	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
11	rs181821555	chr4:119316192-119316193	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
12	rs72670233	chr4:119316237-119316238	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
13	rs574942782	chr4:119316249-119316250	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
14	rs186547528	chr4:119316284-119316285	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
15	rs557284555	chr4:119316313-119316314	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
16	rs34878358	chr4:119316342-119316343	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
17	rs570773943	chr4:119316343-119316344	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
18	rs11934393	chr4:119316366-119316367	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
19	rs189765980	chr4:119316426-119316427	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
20	rs573460291	chr4:119316542-119316543	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
21	rs543526843	chr4:119316548-119316549	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
22	rs554700779	chr4:119316553-119316554	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
23	rs13152458	chr4:119316625-119316626	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
24	rs543161603	chr4:119316649-119316650	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
25	rs200422319	chr4:119316712-119316713	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
26	rs563258516	chr4:119316721-119316722	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
27	rs576794759	chr4:119316747-119316748	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
28	rs576856308	chr4:119316763-119316764	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
29	rs545680331	chr4:119316767-119316768	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
30	rs559265294	chr4:119316784-119316785	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
31	rs537015388	chr4:119316811-119316812	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs535876270	chr4:119316843-119316844	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs545526907	chr4:119316923-119316924	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs115210383	chr4:119316989-119316990	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs547936381	chr4:119317010-119317011	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
36	rs181045925	chr4:119317013-119317014	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
37	rs34289146	chr4:119317014-119317015	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
38	rs185989433	chr4:119317064-119317065	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
39	rs550818255	chr4:119317207-119317208	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
40	rs372831364	chr4:119317208-119317209	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
41	rs17642498	chr4:119317236-119317237	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
42	rs151056762	chr4:119317238-119317239	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
43	rs547305245	chr4:119317247-119317248	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
44	rs374878578	chr4:119317253-119317254	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
45	rs567216844	chr4:119317267-119317268	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
46	rs113764716	chr4:119317305-119317306	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
47	rs141016708	chr4:119317321-119317322	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
48	rs371829406	chr4:119317388-119317389	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
49	rs376366173	chr4:119317513-119317514	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
50	rs7687158	chr4:119317518-119317519	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a

Variant related diseases (count:76)

Disease	PMID	Source
Acute lymphoblastic leukemia	22237106	CNVD
Glioblastoma multiforme	21080181	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Chordoma	21602918	CNVD
HIV/AIDS	22032296	CNVD
Medulloblastoma	21979893	CNVD
Neuroblastoma	18923191	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Autism	22495311	CNVD
Breast cancer	21858162	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Gastric cancer	21586687	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Melanoma	18172304	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Breast cancer	17603634	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Breast cancer	16272173	CNVD
Colorectal cancer	19359472	CNVD
Malignant mesothelioma	18160781	CNVD
Medulloblastoma	18056178	CNVD
Multiple myeloma	17077331	CNVD
Pleural malignant mesothelioma	18160781	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Oral squamous cell carcinoma	17134496	CNVD
4q-syndrome	17576883	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Colorectal cancer	20709793	CNVD
Muscular dystrophy	21149563	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Liposarcoma	21253554	CNVD
Oligodendroglial tumors	17285580	CNVD
Cervical cancer	21062161	CNVD
Metanephric adenoma	20802469	CNVD
Breast cancer	16608533	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Lung cancer	19208797	CNVD
Wilms tumour	21544195	CNVD
Breast cancer	21785460	CNVD
Myelodysplastic syndrome	21251322	CNVD
Lung cancer	18438408	CNVD
Cancer	22429812	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Cancer	21183584	CNVD
primary effusion lymphomas	17116491	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Breast cancer	17133270	CNVD
Colorectal cancer	20459617	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Congenital anomalies of the kidney and urinary tract	20505237	CNVD
Breast cancer	17393978	CNVD
Esophageal cancer	21851588	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Colorectal cancer	16272173	CNVD
Testicular germ cell tumor	18059402	CNVD
Ovarian cancer	22174824	CNVD
Cutaneous T-cell lymphoma	21881587	CNVD
Myelofibrosis	22110671	CNVD
Neuroblastoma	21899760	CNVD
small cell lung cancer	20016488	CNVD
Renal cell carcinoma	18194544	CNVD
Autism	19246517	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Breast cancer	22522925	CNVD
early-passage human iPS cells	21368824	CNVD
Pancreatic cancer	17952125	CNVD
Non-syndromic sensorineural hearing loss	19587683	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD

Chromatin state (count:168 , 50 per page) page: 1 2 3 4

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr4:119311200-119318200	Weak transcription	NHDF-Ad	bronchial
2	chr4:119315200-119316800	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
3	chr4:119315400-119316000	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
4	chr4:119315400-119316800	Enhancers	Fetal Adrenal Gland	Adrenal Gland
5	chr4:119315400-119317200	Enhancers	Breast Myoepithelial Primary Cells	Breast
6	chr4:119315400-119317400	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
7	chr4:119315800-119317000	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
8	chr4:119316000-119316800	Bivalent Enhancer	iPS-15b Cell Line	embryonic stem cell
9	chr4:119316000-119318000	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
10	chr4:119316200-119320000	Enhancers	HUES64 Cell Line	embryonic stem cell
11	chr4:119316200-119320800	Enhancers	ES-I3 Cell Line	embryonic stem cell
12	chr4:119316600-119316800	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
13	chr4:119316800-119317000	Enhancers	iPS-18 Cell Line	embryonic stem cell
14	chr4:119316800-119318000	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
15	chr4:119316800-119318000	Weak transcription	Fetal Adrenal Gland	Adrenal Gland
16	chr4:119316800-119321600	Weak transcription	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
17	chr4:119317000-119317800	Weak transcription	iPS-18 Cell Line	embryonic stem cell
18	chr4:119317000-119318200	Bivalent Enhancer	HUES6 Cell Line	embryonic stem cell
19	chr4:119317000-119318600	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived
20	chr4:119317000-119319600	Bivalent Enhancer	iPS-15b Cell Line	embryonic stem cell
21	chr4:119317200-119317600	Weak transcription	Breast Myoepithelial Primary Cells	Breast
22	chr4:119317600-119318400	Enhancers	H1 Cell Line	embryonic stem cell
23	chr4:119317600-119318400	Enhancers	HUES48 Cell Line	embryonic stem cell
24	chr4:119317600-119319200	Enhancers	H9 Cell Line	embryonic stem cell
25	chr4:119317600-119319600	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
26	chr4:119317600-119319800	Enhancers	Breast Myoepithelial Primary Cells	Breast
27	chr4:119317800-119318400	Enhancers	Placenta	Placenta
28	chr4:119317800-119318600	Enhancers	iPS-18 Cell Line	embryonic stem cell
29	chr4:119317800-119320000	Enhancers	iPS-20b Cell Line	embryonic stem cell
30	chr4:119317800-119320200	Enhancers	HMEC	breast
31	chr4:119318000-119318200	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
32	chr4:119318000-119319800	Enhancers	ES-WA7 Cell Line	embryonic stem cell
33	chr4:119318000-119319800	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
34	chr4:119318000-119320200	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
35	chr4:119318000-119320200	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
36	chr4:119318000-119322200	Enhancers	Fetal Adrenal Gland	Adrenal Gland
37	chr4:119318200-119318800	Enhancers	NHDF-Ad	bronchial
38	chr4:119318200-119319000	Enhancers	NHEK	skin
39	chr4:119318200-119319800	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
40	chr4:119318200-119319800	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
41	chr4:119318200-119322600	Enhancers	HUES6 Cell Line	embryonic stem cell
42	chr4:119318400-119318800	Weak transcription	H1 Cell Line	embryonic stem cell
43	chr4:119318400-119318800	Weak transcription	HUES48 Cell Line	embryonic stem cell
44	chr4:119318400-119318800	Weak transcription	Placenta	Placenta
45	chr4:119318400-119320400	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
46	chr4:119318400-119321800	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
47	chr4:119318400-119323200	Enhancers	Primary hematopoietic stem cells	blood
48	chr4:119318400-119323800	Enhancers	Primary hematopoietic stem cells short term culture	blood
49	chr4:119318600-119319200	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
50	chr4:119318600-119319200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links